FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly pharmaceutical preparations, namely: plasters for transdermal application. What is described is a transdermal plaster representing a matrix system and comprising a lining layer, a matrix layer and a lightproof protective coating in the following proportions: mexidol substance (4.59 wt %), propylene glycol 10.32 wt %, PVP K90 (Plasdone K90) 10.09 wt %, 95% ethanol 75.0 wt %. The plaster aims at the transdermal introduction of mexidol. A plaster area is 25 cm2.
EFFECT: plaster is used for treating and preventing chronic diseases, allows avoiding the problems related to oral administration, improves patient compliance; it is applicable in children and elderly persons, suitable for purposes of combination therapy.
5 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL PLASTER | 2010 |
|
RU2445084C2 |
| TRANSDERMATIC PLASTER WITH GLYCAZIDE | 2019 |
|
RU2736081C1 |
| MATRIX BASED ON ACRYLIC ADHESIVE WITH COMPLEX OF TRANSDERMAL TRANSFER ACTIVATORS FOR TRANSDERMAL THERAPEUTIC SYSTEMS | 2023 |
|
RU2812184C1 |
| PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ALPRAZOLAM | 2018 |
|
RU2694232C1 |
| THERMOFUSIBLE TTS FOR APPLYING ROTIGOTIN | 2003 |
|
RU2304434C2 |
| TRANSDERMAL PLASTER FOR INTRODUCING 17-DEACETYLNORHESTIMATE SEPARATELY OR IN COMBINATION WITH ESTROGEN | 1996 |
|
RU2177311C2 |
| MEDICINAL FILM CONTAINING MELATONIN FOR THE TREATMENT OF THERMAL INJURY | 2020 |
|
RU2751048C1 |
| HIGHLY PURE 3,3-DIPHENYLPROPYLAMINO MONOESTERS | 2004 |
|
RU2394019C2 |
| DEXMEDETOMIDINE TRANSDERMAL DELIVERY DEVICES AND METHODS FOR USING THE SAME | 2014 |
|
RU2646512C2 |
| METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF A NON-SEDATIVE AMOUNT OF DEXMEDETOMIDINE | 2014 |
|
RU2648449C2 |
